ArticlePloS one2026
A computational method to estimate the relative biological effectiveness and tumor control probability for low-LET proton irradiations.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A constant relative biological effectiveness (RBE) value of 1.1 is used for proton therapy (PT) in many clinical treatment plans. However, several studies show that RBE varies with proton energy, linear energy transfer (LET), and oxygen concentration. This study presents a computational method based on the linear quadratic (LQ) and repair-misrepair-fixation (RMF) models to calculate tumor control probability (TCP) under varying oxygen conditions. We analyze the impact of hypoxia on the parameters of the LQ model, focusing on the ratio and RBE. The proposed method allows for TCP calculations across different oxygen concentrations and for various ion therapies, such as proton and carbon ion therapy. Our results show that increasing the LET from 1 to 12 keV/μm enhances TCP from 61% to 98% under aerobic conditions (21% O2), 45% to 98% under moderately hypoxic conditions (2% O2), and from 1% to 48% under severely hypoxic conditions (0.1% O2). These findings are compared with clinical trial data, demonstrating that hypoxia significantly affects TCP for low-LET radiations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.